# BIAGON, INC.: Discovering Biased Antagonists of CXCR2 as Drug Leads for Acute Lung Injury

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | BIAGON, INC. |
| Location | CHICAGO, IL |
| Project | Discovering Biased Antagonists of CXCR2 as Drug Leads for Acute Lung Injury |
| Project number | 1R41HL187112-01 |
| Mechanism | R41 |
| Institute | National Heart Lung and Blood Institute |
| Award | $349,997 |
| Awarded | 2026-09-09 |
| Project period | 2026-09-10 to 2027-08-31 |
| UEI | KC22MJKDF1R1 |

## Why this score
- Award of $349,997.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409876). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.